JP2022509077A - 表面欠陥が形成された酸化セリウム粒子を含む日焼け止め組成物、及びその製造方法 - Google Patents
表面欠陥が形成された酸化セリウム粒子を含む日焼け止め組成物、及びその製造方法 Download PDFInfo
- Publication number
- JP2022509077A JP2022509077A JP2021527125A JP2021527125A JP2022509077A JP 2022509077 A JP2022509077 A JP 2022509077A JP 2021527125 A JP2021527125 A JP 2021527125A JP 2021527125 A JP2021527125 A JP 2021527125A JP 2022509077 A JP2022509077 A JP 2022509077A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- cerium oxide
- sunscreen composition
- oxide particles
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910000420 cerium oxide Inorganic materials 0.000 title claims abstract description 128
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 title claims abstract description 128
- 239000002245 particle Substances 0.000 title claims abstract description 122
- 230000000475 sunscreen effect Effects 0.000 title claims abstract description 102
- 239000000516 sunscreening agent Substances 0.000 title claims abstract description 99
- 239000000203 mixture Substances 0.000 title claims abstract description 80
- 230000007547 defect Effects 0.000 title claims abstract description 45
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 29
- 239000002253 acid Substances 0.000 claims description 49
- 125000004432 carbon atom Chemical group C* 0.000 claims description 27
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 22
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 22
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 21
- 239000000194 fatty acid Substances 0.000 claims description 21
- 229930195729 fatty acid Natural products 0.000 claims description 21
- 150000004665 fatty acids Chemical class 0.000 claims description 21
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 20
- 239000000126 substance Substances 0.000 claims description 20
- 239000008346 aqueous phase Substances 0.000 claims description 17
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 17
- HSJPMRKMPBAUAU-UHFFFAOYSA-N cerium(3+);trinitrate Chemical compound [Ce+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O HSJPMRKMPBAUAU-UHFFFAOYSA-N 0.000 claims description 16
- 229910044991 metal oxide Inorganic materials 0.000 claims description 16
- 150000004706 metal oxides Chemical class 0.000 claims description 16
- -1 diethylamino hydroxybenzoyl benzoic acid hexyl (diethylamino Hydroxybenzoyl hexyl Benzoate) Chemical compound 0.000 claims description 14
- 238000003801 milling Methods 0.000 claims description 13
- 239000003960 organic solvent Substances 0.000 claims description 11
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 claims description 10
- UTOPWMOLSKOLTQ-UHFFFAOYSA-N octacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O UTOPWMOLSKOLTQ-UHFFFAOYSA-N 0.000 claims description 10
- 239000011163 secondary particle Substances 0.000 claims description 10
- 238000001069 Raman spectroscopy Methods 0.000 claims description 9
- 238000004458 analytical method Methods 0.000 claims description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 claims description 8
- YBMRDBCBODYGJE-UHFFFAOYSA-N germanium dioxide Chemical compound O=[Ge]=O YBMRDBCBODYGJE-UHFFFAOYSA-N 0.000 claims description 8
- VXZBFBRLRNDJCS-UHFFFAOYSA-N heptacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O VXZBFBRLRNDJCS-UHFFFAOYSA-N 0.000 claims description 8
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 8
- 239000011164 primary particle Substances 0.000 claims description 8
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 7
- VYLVYHXQOHJDJL-UHFFFAOYSA-K cerium trichloride Chemical compound Cl[Ce](Cl)Cl VYLVYHXQOHJDJL-UHFFFAOYSA-K 0.000 claims description 7
- DRVWBEJJZZTIGJ-UHFFFAOYSA-N cerium(3+);oxygen(2-) Chemical class [O-2].[O-2].[O-2].[Ce+3].[Ce+3] DRVWBEJJZZTIGJ-UHFFFAOYSA-N 0.000 claims description 7
- WXPWZZHELZEVPO-UHFFFAOYSA-N (4-methylphenyl)-phenylmethanone Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=CC=C1 WXPWZZHELZEVPO-UHFFFAOYSA-N 0.000 claims description 6
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 claims description 6
- HKVFISRIUUGTIB-UHFFFAOYSA-O azanium;cerium;nitrate Chemical compound [NH4+].[Ce].[O-][N+]([O-])=O HKVFISRIUUGTIB-UHFFFAOYSA-O 0.000 claims description 6
- UNJPQTDTZAKTFK-UHFFFAOYSA-K cerium(iii) hydroxide Chemical compound [OH-].[OH-].[OH-].[Ce+3] UNJPQTDTZAKTFK-UHFFFAOYSA-K 0.000 claims description 6
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims description 6
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 6
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 claims description 6
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 claims description 6
- XMHIUKTWLZUKEX-UHFFFAOYSA-N hexacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O XMHIUKTWLZUKEX-UHFFFAOYSA-N 0.000 claims description 6
- MWMPEAHGUXCSMY-UHFFFAOYSA-N pentacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCC(O)=O MWMPEAHGUXCSMY-UHFFFAOYSA-N 0.000 claims description 6
- 235000003441 saturated fatty acids Nutrition 0.000 claims description 6
- 229910018072 Al 2 O 3 Inorganic materials 0.000 claims description 5
- GHLITDDQOMIBFS-UHFFFAOYSA-H cerium(3+);tricarbonate Chemical compound [Ce+3].[Ce+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O GHLITDDQOMIBFS-UHFFFAOYSA-H 0.000 claims description 5
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 claims description 5
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 claims description 5
- 235000020664 gamma-linolenic acid Nutrition 0.000 claims description 5
- 229960002733 gamolenic acid Drugs 0.000 claims description 5
- 229910005793 GeO 2 Inorganic materials 0.000 claims description 4
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 4
- CETPSERCERDGAM-UHFFFAOYSA-N ceric oxide Chemical compound O=[Ce]=O CETPSERCERDGAM-UHFFFAOYSA-N 0.000 claims description 4
- 229910000422 cerium(IV) oxide Inorganic materials 0.000 claims description 4
- HUVYTMDMDZRHBN-UHFFFAOYSA-N drometrizole trisiloxane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)CC(C)CC1=CC(C)=CC(N2N=C3C=CC=CC3=N2)=C1O HUVYTMDMDZRHBN-UHFFFAOYSA-N 0.000 claims description 4
- CKDDRHZIAZRDBW-UHFFFAOYSA-N henicosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCC(O)=O CKDDRHZIAZRDBW-UHFFFAOYSA-N 0.000 claims description 4
- 229960002248 meradimate Drugs 0.000 claims description 4
- ISYWECDDZWTKFF-UHFFFAOYSA-N nonadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCCC(O)=O ISYWECDDZWTKFF-UHFFFAOYSA-N 0.000 claims description 4
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 claims description 4
- 229960001173 oxybenzone Drugs 0.000 claims description 4
- 229940100498 polysilicone-15 Drugs 0.000 claims description 4
- 229920002282 polysilicones-15 Polymers 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 claims description 4
- 229960000368 sulisobenzone Drugs 0.000 claims description 4
- 230000002194 synthesizing effect Effects 0.000 claims description 4
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 claims description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 3
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 claims description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 3
- HMKKFLSUPRUBOO-IUPFWZBJSA-N 3,4-dihydroxy-5-[3,4,5-tris[[(z)-octadec-9-enoyl]oxy]benzoyl]oxybenzoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC1=C(OC(=O)CCCCCCC\C=C/CCCCCCCC)C(OC(=O)CCCCCCC\C=C/CCCCCCCC)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(O)=O)O)=C1 HMKKFLSUPRUBOO-IUPFWZBJSA-N 0.000 claims description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 3
- YUIFLPUCUQIUND-UHFFFAOYSA-N COC(C(=O)OCCCCCCCC)=CC1=CC=CC=C1.COC(C(=O)O)=CC1=CC=CC=C1 Chemical compound COC(C(=O)OCCCCCCCC)=CC1=CC=CC=C1.COC(C(=O)O)=CC1=CC=CC=C1 YUIFLPUCUQIUND-UHFFFAOYSA-N 0.000 claims description 3
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 claims description 3
- 235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 claims description 3
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims description 3
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 claims description 3
- 239000005639 Lauric acid Substances 0.000 claims description 3
- 235000021353 Lignoceric acid Nutrition 0.000 claims description 3
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 claims description 3
- 239000005642 Oleic acid Substances 0.000 claims description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 3
- 235000021314 Palmitic acid Nutrition 0.000 claims description 3
- 235000021322 Vaccenic acid Nutrition 0.000 claims description 3
- UWHZIFQPPBDJPM-FPLPWBNLSA-M Vaccenic acid Natural products CCCCCC\C=C/CCCCCCCCCC([O-])=O UWHZIFQPPBDJPM-FPLPWBNLSA-M 0.000 claims description 3
- 229960005193 avobenzone Drugs 0.000 claims description 3
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 claims description 3
- GLCJMPWWQKKJQZ-UHFFFAOYSA-L disodium;2-[4-(4,6-disulfonato-1h-benzimidazol-2-yl)phenyl]-1h-benzimidazole-4,6-disulfonate;hydron Chemical compound [Na+].[Na+].C1=C(S(O)(=O)=O)C=C2NC(C3=CC=C(C=C3)C3=NC4=C(C=C(C=C4N3)S(=O)(=O)O)S([O-])(=O)=O)=NC2=C1S([O-])(=O)=O GLCJMPWWQKKJQZ-UHFFFAOYSA-L 0.000 claims description 3
- FARYTWBWLZAXNK-WAYWQWQTSA-N ethyl (z)-3-(methylamino)but-2-enoate Chemical compound CCOC(=O)\C=C(\C)NC FARYTWBWLZAXNK-WAYWQWQTSA-N 0.000 claims description 3
- 229940068171 ethyl hexyl salicylate Drugs 0.000 claims description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 3
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims description 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 3
- SZHOJFHSIKHZHA-UHFFFAOYSA-N n-Tridecanoic acid Natural products CCCCCCCCCCCCC(O)=O SZHOJFHSIKHZHA-UHFFFAOYSA-N 0.000 claims description 3
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 claims description 3
- 229960000601 octocrylene Drugs 0.000 claims description 3
- 235000021313 oleic acid Nutrition 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- UWHZIFQPPBDJPM-BQYQJAHWSA-N trans-vaccenic acid Chemical compound CCCCCC\C=C\CCCCCCCCCC(O)=O UWHZIFQPPBDJPM-BQYQJAHWSA-N 0.000 claims description 3
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 claims description 2
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 claims description 2
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 claims description 2
- ICPMSVOCDXTTPU-UHFFFAOYSA-N C=C(C(C1=C(C(=C(C(=C1C)C)C)C)O)(C1=CC=CC=2NN=NC21)C2=CC=CC=1NN=NC12)CC.C=C(C(C1=C(C(=C(C(=C1C)C)C)C)O)(C1=CC=CC=2NN=NC21)C2=CC=CC=1NN=NC12)CC Chemical compound C=C(C(C1=C(C(=C(C(=C1C)C)C)C)O)(C1=CC=CC=2NN=NC21)C2=CC=CC=1NN=NC12)CC.C=C(C(C1=C(C(=C(C(=C1C)C)C)C)O)(C1=CC=CC=2NN=NC21)C2=CC=CC=1NN=NC12)CC ICPMSVOCDXTTPU-UHFFFAOYSA-N 0.000 claims description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 2
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 claims description 2
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims description 2
- 229960004488 linolenic acid Drugs 0.000 claims description 2
- SOXAGEOHPCXXIO-DVOMOZLQSA-N menthyl anthranilate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1N SOXAGEOHPCXXIO-DVOMOZLQSA-N 0.000 claims description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 claims description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 claims 2
- 235000021357 Behenic acid Nutrition 0.000 claims 1
- 229940116226 behenic acid Drugs 0.000 claims 1
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 claims 1
- 239000006185 dispersion Substances 0.000 abstract description 13
- 230000001580 bacterial effect Effects 0.000 abstract description 6
- 230000037072 sun protection Effects 0.000 abstract description 4
- 238000000926 separation method Methods 0.000 abstract description 2
- 239000002537 cosmetic Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000000243 solution Substances 0.000 description 11
- 239000002552 dosage form Substances 0.000 description 10
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 239000004408 titanium dioxide Substances 0.000 description 6
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-hydroxyoctadecanoic acid Chemical group CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 241000894007 species Species 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- JLFUROOGQPXGSU-UHFFFAOYSA-N C(CCCCCCCCCCCCCCCCC)(=[O+][O-])O Chemical compound C(CCCCCCCCCCCCCCCCC)(=[O+][O-])O JLFUROOGQPXGSU-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000004909 Moisturizer Substances 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 230000002147 killing effect Effects 0.000 description 4
- 230000001333 moisturizer Effects 0.000 description 4
- 239000011787 zinc oxide Substances 0.000 description 4
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 3
- 239000012695 Ce precursor Substances 0.000 description 3
- 229910052684 Cerium Inorganic materials 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OOHTWBUKWQKKEE-UHFFFAOYSA-N [6-(diethylamino)-6-hydroxy-7-oxo-7-phenylheptyl] benzoate Chemical compound C=1C=CC=CC=1C(=O)C(O)(N(CC)CC)CCCCCOC(=O)C1=CC=CC=C1 OOHTWBUKWQKKEE-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 159000000007 calcium salts Chemical class 0.000 description 3
- GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical compound [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 238000001027 hydrothermal synthesis Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000003002 pH adjusting agent Substances 0.000 description 3
- 230000001699 photocatalysis Effects 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 206010051246 Photodermatosis Diseases 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- NGLMYMJASOJOJY-UHFFFAOYSA-O azanium;calcium;nitrate Chemical compound [NH4+].[Ca].[O-][N+]([O-])=O NGLMYMJASOJOJY-UHFFFAOYSA-O 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- OSPYXUDVXSLVLJ-UHFFFAOYSA-N calcium cerium(3+) oxygen(2-) Chemical compound [Ca+2].[O-2].[Ce+3] OSPYXUDVXSLVLJ-UHFFFAOYSA-N 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 230000008845 photoaging Effects 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- VHOCUJPBKOZGJD-UHFFFAOYSA-N triacontanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O VHOCUJPBKOZGJD-UHFFFAOYSA-N 0.000 description 2
- XEZVDURJDFGERA-UHFFFAOYSA-N tricosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCC(O)=O XEZVDURJDFGERA-UHFFFAOYSA-N 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- XVEIGUQEXNENQF-LNMUMINZSA-N (6Z,9Z,12Z)-octadeca-6,9,12-trienoic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O.CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O XVEIGUQEXNENQF-LNMUMINZSA-N 0.000 description 1
- AQQWWUIGQFJCMJ-OQQRQXPPSA-N (9z,12z,15z)-octadeca-9,12,15-trienoic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O.CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O AQQWWUIGQFJCMJ-OQQRQXPPSA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- VKTKSVRJLNRCQA-UHFFFAOYSA-N 2-[1,1-bis(2H-benzotriazol-4-yl)butyl]-3,4,5,6-tetramethylphenol Chemical compound N1N=NC2=C1C=CC=C2C(CCC)(C1=C(C(=C(C(=C1C)C)C)C)O)C1=CC=CC=2NN=NC=21 VKTKSVRJLNRCQA-UHFFFAOYSA-N 0.000 description 1
- USNOSXAWMRGURQ-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C(CCC)C(C(C1=CC=CC=C1)=O)(C(C1=CC=CC=C1)=O)OC.C(CCC)C(C(C1=CC=CC=C1)=O)(C(C1=CC=CC=C1)=O)OC USNOSXAWMRGURQ-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- MSPJNHHBNOLHOC-UHFFFAOYSA-N 3,3-dimethylcyclopropane-1,2-dicarboxylic acid Chemical compound CC1(C)C(C(O)=O)C1C(O)=O MSPJNHHBNOLHOC-UHFFFAOYSA-N 0.000 description 1
- ZUYVPAKYYMBQBT-UHFFFAOYSA-N 3,4-diethyl-2-hexoxyphenol Chemical compound CCCCCCOC1=C(O)C=CC(CC)=C1CC ZUYVPAKYYMBQBT-UHFFFAOYSA-N 0.000 description 1
- GNKZMNRKLCTJAY-UHFFFAOYSA-N 4'-Methylacetophenone Chemical compound CC(=O)C1=CC=C(C)C=C1 GNKZMNRKLCTJAY-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 235000017822 Melilotus officinalis Nutrition 0.000 description 1
- 240000000366 Melilotus officinalis Species 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical class OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 240000002547 Rosa roxburghii Species 0.000 description 1
- 235000000640 Rosa roxburghii Nutrition 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 108010045569 atelocollagen Proteins 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 1
- 229960001063 cinoxate Drugs 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000000490 cosmetic additive Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- AGDANEVFLMAYGL-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCCCCCC(O)=O AGDANEVFLMAYGL-UHFFFAOYSA-N 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 229960000979 drometrizole Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 229960000655 ensulizole Drugs 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical class OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229940035429 isobutyl alcohol Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000004533 oil dispersion Substances 0.000 description 1
- 150000002894 organic compounds Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229930195143 oxyphenol Natural products 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 239000011342 resin composition Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- VBGUQBPWJMPQBI-UHFFFAOYSA-M sodium;butanedioic acid;4-hydroxy-4-oxobutanoate Chemical compound [Na+].OC(=O)CCC(O)=O.OC(=O)CCC([O-])=O VBGUQBPWJMPQBI-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000006104 solid solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- JYQXULADMIJVOA-UHFFFAOYSA-K trisodium 2-hydroxypropane-1,2,3-tricarboxylate 2-hydroxypropanoic acid Chemical compound [Na+].[Na+].[Na+].CC(O)C(O)=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O JYQXULADMIJVOA-UHFFFAOYSA-K 0.000 description 1
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000012463 white pigment Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0275—Containing agglomerated particulates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/61—Surface treated
- A61K2800/612—By organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/61—Surface treated
- A61K2800/614—By macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
ステップ1:表面欠陥が形成された酸化セリウム粒子の製造
酸化セリウム前駆体でもって硝酸セリウム(cerium nitrate)を上向き方式(Bottom up)にて、化学的合成方法である水熱反応により粒子を成長させた。前記硝酸セリウム100重量部、及び硝酸セリウム100重量部を基準として、硝酸アルミニウム1重量部を脱イオン水500重量部に添加して撹拌しながら、アンモニア水200重量部を添加し、pHが10になっている前駆体溶液を製造した。前記前駆体溶液を水熱合成器に入れ、180℃で24時間の間反応させて、アルミナにより表面欠陥が形成された酸化セリウム粒子を製造した。前記粒子を遠心分離して未反応物を除去した。前記未反応物が除去された、アルミナが含有された酸化セリウムは、前記酸化セリウムの合計100wt%に対してアルミナ0.01wt%で含有し、一次粒子径が20.1nmであった。前記未反応物が除去された表面欠陥が形成された酸化セリウムを120℃で4時間の間乾燥させてパウダーを得た。図1に表面欠陥が形成された酸化セリウム粒子の模式図を示し、図2に、表面欠陥が形成された酸化セリウム粒子をラマン分析したグラフを示した。
脱イオン水2,500gにpH調節剤(硝酸等)50gを添加した後、撹拌した。前記製造された溶液に、前記ステップ1で製造した表面欠陥が形成された酸化セリウム粒子2,000gを添加した後、ビーズミル装備によるミリング(摩砕)を行って、水分散された酸化セリウム分散液を得た。
前記実施例1のステップ1の過程において、硝酸アルミニウムを処理せず、酸化セリウムを単純にか焼(かしょう)させたことを除いては、前記実施例1と同様な方法で酸化セリウム分散液を製造した。
前記比較例及び実施例の酸化セリウム分散液に含まれた酸化セリウム粒子のラマン分析を行い、それぞれ図3a及び3bに示した。表面欠陥のない酸化セリウム粒子の場合、図3aに示すように、約460cm-1においてピークが検出されたが、表面欠陥のある酸化セリウム粒子の場合、図3bに示すように、約595cm-1においてピークが検出されたことが確認された。
前記比較例及び実施例の酸化セリウム分散液の菌種死滅効能を測定して、図4に写真で示した。図4に示すように、実施例に相当する酸化セリウム分散液の場合、比較例に比べて菌種死滅効能に優れることが確認された。
Claims (16)
- Ce4+及びCe3+を含む表面欠陥が形成された酸化セリウム粒子を含む日焼け止め組成物。
- 前記酸化セリウム粒子は、ラマン分析の際に、550cm-1乃至650cm-1においてピークが検出されるものである請求項1に記載の日焼け止め組成物。
- 前記Ce3+及びCe4+の重量割合は、1:0.3乃至0.8である請求項1に記載の日焼け止め組成物。
- 前記酸化セリウム粒子は、炭素数10乃至30の飽和脂肪酸、炭素数10乃至30の不飽和脂肪酸、またはポリヒドロキシステアリン酸でもって表面改質されたものである請求項1に記載の日焼け止め組成物。
- 前記炭素数10乃至30の飽和脂肪酸は、カプリン酸(Capric acid)、ウンデシル酸(Undecylic acid)、ラウリン酸(Lauric acid)、トリデシル酸(Tridecylic acid)、ミリスチン酸(Myristic acid)、パルミチン酸(Palmitic acid)、マルガリン酸(Margaric acid)、ステアリン酸(Stearic acid)、ノナデカノン酸(Nonadecylic acid)、アラキン酸(Arachidic acid)、ヘンイコサノン酸(Heneicosanoic acid)、ベヘン酸(Behenic acid)、トリコサン酸(Tricosanoic acid)、リグノセリン酸(Lignoceric acid)、ペンタコサン酸(Pentacosanoic acid)、セロチン酸(Cerotic acid)、ヘプタコサン酸(Heptacosanoic acid)、モンタン酸(Montanic acid)、ノナコサン酸(Nonacosanoic acid)、メリシン酸(Melissic acid)、及びこれらの組み合わせからなる群から選ばれる脂肪酸を含むものである請求項4に記載の日焼け止め組成物。
- 前記炭素数10乃至30の不飽和脂肪酸は、炭素数と二重結合数の比が18:1乃至18:3である請求項4に記載の日焼け止め組成物。
- 前記炭素数10乃至30の不飽和脂肪酸は、α-リノレン酸(α-Linolenic acid)、リノール酸(Linoleic acid)、γ-リノレン酸(γ-Linolenic acid)、ジホモ-γ-リノレン酸(Dihomo-γ-linolenic acid)、パルミトレイン酸(Palmitoleic acid)、バクセン酸(Vaccenic acid)、オレイン酸(Oleic acid)、トランス-エライジン酸(trans-elaidic acid)、及びこれらの組み合わせからなる群から選ばれる脂肪酸を含むものである請求項4に記載の日焼け止め組成物。
- 前記飽和脂肪酸、不飽和脂肪酸、またはポリヒドロキシステアリン酸の含量は、表面改質された酸化セリウム(CeO2)粒子100重量部に対して1重量部乃至10重量部である請求項4に記載の日焼け止め組成物。
- 前記酸化セリウム粒子の含量は、全体の日焼け止め組成物100重量部に対して5重量部乃至30重量部である請求項1に記載の日焼け止め組成物。
- 前記酸化セリウム(CeO2)は、1次粒子径が10乃至30nmであり、2次粒子径が100乃至200nmであり、1次粒子径に対する2次粒子径の割合が3乃至20である請求項1に記載の日焼け止め組成物。
- 前記日焼け止め組成物は、有機系日焼け止めをさらに含むものである請求項1に記載の日焼け止め組成物。
- 前記有機系日焼け止めは、メトキシケイヒ酸オクチル(octyl methoxycinnamate)、サリチル酸エチルヘキシル(ethylhexylsalicylate)、ホモサレート(homosalate)、4-メチルベンジリデンカンファー(4-Methylbenzylidene Camphor)、ドロメトリゾール(Drometrizole)、ドロメトリゾールトリシロキサン(Drometrizole trisiloxane)、ジガロイルトリオレエート(Digalloyl Trioleate)、フェニルジベンズイミダゾールテトラスルホン酸二ナトリウム(Disodium Phenyl Dibenzimidazole Tetrasulfonate Acid)、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル(Diethylamino Hydroxybenzoyl Hexyl Benzoate)、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル(Diethylamino Hydroxybenzoyl Hexyl Benzoate)、ジエチルヘキシルブタミドトリアゾン(Diethylhexyl Butamido Triazone)、メチレンビス-ベンゾトリアゾリルテトラメチルブチルフェノール(Methylene Bis-Benzotriazolyl Tetramethylbutylphenol)、アントラニル酸メンチル(Menthyl Anthranilate)、ベンゾフェノン-3(Benzophenone-3)、ベンゾフェノン-4(Benzophenone-4)、ベンゾフェノン-8(Benzophenone-8)、ブチルメトキシジベンゾイルメタン(Butyl Methoxydibenzoylmethane)、ビスエチルヘキシルオキシフェノールメトキシフェニルトリアジン(Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine)、シノキセート(Cinoxate)、ジメチルPABAエチルヘキシル(Ethylhexyl Dimethyl PABA)、メトキシケイ皮酸エチルヘキシル(Ethylhexyl Methoxycinnamate)、エチルヘキシルトリアゾン(Ethylhexyl Triazone)、オクトクリレン(Octocrylene)、パラメトキシケイヒ酸イソアミル(Isoamyl p-Methoxycinnamate)、テレフタリリデンジカンフルスルホン酸(Terephthalylidene Dicamphor Sulfonic Acid)、フェニルベンズイミダゾールスルホン酸(Phenylbenzimidazole Sulfonic Acid)、ポリシリコーン-15(Polysilicone-15)、及びこれらの組み合わせからなる群から選ばれる物質を含む請求項11に記載の日焼け止め組成物。
- 水酸化セリウム(cerium hydroxide)、酸化セリウム(cerium oxide)、炭酸セリウム(cerium carbonate)、硝酸セリウム(cerium nitrate)、塩化セリウム(cerium chloride)、硝酸アンモニウムセリウム(ammonium cerium nitrate)、及びこれらの組み合わせからなる群から選ばれる物質を水熱合成して、酸化セリウム(CeO2)粒子を得るステップと、
前記得られたた酸化セリウム(CeO2)粒子に金属酸化物溶液を添加し、水熱合成して、Ce3+を含む表面欠陥が形成された酸化セリウム粒子を製造するステップと、を含む日焼け止め組成物の製造方法。 - 前記金属酸化物溶液において、金属酸化物は、アルミナ(Al2O3)、セリア(CeO2)、シリカ(SiO2)、ジルコニア(ZrO2)、チタニア(TiO2)、ゲルマニア(GeO2)、及びこれらの組み合わせからなる群から選ばれる物質を含むものである請求項13に記載の日焼け止め組成物の製造方法。
- 前記日焼け止め組成物の製造方法は、表面欠陥が形成された酸化セリウム粒子を製造するステップ以後に、
前記製造された表面欠陥が形成された酸化セリウム粒子を水相媒質に添加するステップと、
前記水相媒質に対してミリングを行うステップと、をさらに含むものである請求項13に記載の日焼け止め組成物の製造方法。 - 前記日焼け止め組成物の製造方法は、表面欠陥が形成された酸化セリウム粒子を製造するステップの後に、
前記製造された表面欠陥が形成された酸化セリウム粒子に、飽和脂肪酸または不飽和脂肪酸を加えて撹拌して、炭素数10乃至30の飽和脂肪酸または炭素数10乃至30の不飽和脂肪酸でもって表面改質された酸化セリウム(CeO2)粒子を得るか、または、置換若しくは非置換されたポリヒドロキシステアリン酸を加えて撹拌して、ポリヒドロキシステアリン酸でもって表面改質された酸化セリウム(CeO2)粒子を得るステップと、
前記脂肪酸またはポリヒドロキシステアリン酸でもって表面改質された酸化セリウム(CeO2)粒子を有機溶媒に分散させるステップと、
前記有機溶媒に対してミリングを行うステップと、をさらに含むものである請求項13に記載の日焼け止め組成物の製造方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180142915A KR102678102B1 (ko) | 2018-11-19 | 2018-11-19 | 표면결함된 세륨옥사이드 입자를 포함하는 자외선 차단제 조성물 및 이의 제조방법 |
KR10-2018-0142915 | 2018-11-19 | ||
PCT/KR2019/015886 WO2020106037A1 (ko) | 2018-11-19 | 2019-11-19 | 표면결함된 세륨옥사이드 입자를 포함하는 자외선 차단제 조성물 및 이의 제조방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2022509077A true JP2022509077A (ja) | 2022-01-20 |
Family
ID=70773525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021527125A Pending JP2022509077A (ja) | 2018-11-19 | 2019-11-19 | 表面欠陥が形成された酸化セリウム粒子を含む日焼け止め組成物、及びその製造方法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20210401687A1 (ja) |
EP (1) | EP3884925A4 (ja) |
JP (1) | JP2022509077A (ja) |
KR (1) | KR102678102B1 (ja) |
CN (1) | CN113056255B (ja) |
WO (1) | WO2020106037A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115819998B (zh) * | 2022-12-19 | 2023-08-25 | 上海联锴新材料有限公司 | 一种改性二氧化铈纳米片粉体及其制备方法 |
CN116328824B (zh) * | 2023-03-28 | 2023-10-13 | 上海翊嘉生物科技有限公司 | 一种缺陷分子筛锚定的氧化铈团簇纳米酶、及其制备方法和应用 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007504091A (ja) * | 2003-05-21 | 2007-03-01 | ハンファ ケミカル コーポレイション | 金属酸化物固溶体、その製造および用途 |
JP2008279056A (ja) * | 2007-05-10 | 2008-11-20 | Toshiba Corp | 衣類洗濯機 |
US20110097288A1 (en) * | 2009-10-26 | 2011-04-28 | Frank Janssen | Sun Protection Composition |
JP2012521442A (ja) * | 2009-03-23 | 2012-09-13 | コボ プロダクツ インコーポレイテッド | 自己分散性金属酸化物コーティング粉末、その製造方法及び使用 |
CN106745166A (zh) * | 2016-11-24 | 2017-05-31 | 郑州轻工业学院 | 一种量子点氧化铈/改性氧化铈纳米材料的合成方法 |
US9669055B1 (en) * | 2014-04-11 | 2017-06-06 | Marshall University Research Corporation | Methods for treating sepsis |
CN107286540A (zh) * | 2017-08-03 | 2017-10-24 | 合肥安力电力工程有限公司 | 一种阻燃耐候高强电力穿线管材及其制备方法 |
CN107880324A (zh) * | 2017-11-14 | 2018-04-06 | 常德金德新材料科技股份有限公司 | 一种壳聚糖/多层杂化纳米粒子抗菌保鲜膜的制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5424055A (en) * | 1992-03-23 | 1995-06-13 | Mitsui Mining & Smelting Co., Ltd. | Ultraviolet screening composited oxide and process for producing the same |
JP3992402B2 (ja) | 1999-05-25 | 2007-10-17 | 株式会社コーセー | 金属酸化物固溶酸化セリウムからなる紫外線遮断剤並びにそれを配合した樹脂組成物及び化粧料 |
KR20070050347A (ko) * | 2005-11-10 | 2007-05-15 | 정인 | 세륨 옥사이드 화합물의 제조방법 |
FR2933614B1 (fr) * | 2008-07-10 | 2010-09-10 | Oreal | Kit de protection solaire. |
FR3026008B1 (fr) * | 2014-09-19 | 2016-11-25 | Oreal | Composition a base de particules composites spheriques multicouches et d'un filtre uv |
FR3041528A1 (fr) * | 2015-09-25 | 2017-03-31 | Rhodia Operations | Composition cosmetique photoprotectrice |
KR20170142617A (ko) | 2016-06-20 | 2017-12-28 | 추석호 | 글루건 커팅 장치 |
-
2018
- 2018-11-19 KR KR1020180142915A patent/KR102678102B1/ko active IP Right Grant
-
2019
- 2019-11-19 CN CN201980076170.9A patent/CN113056255B/zh active Active
- 2019-11-19 WO PCT/KR2019/015886 patent/WO2020106037A1/ko unknown
- 2019-11-19 JP JP2021527125A patent/JP2022509077A/ja active Pending
- 2019-11-19 US US17/294,566 patent/US20210401687A1/en active Pending
- 2019-11-19 EP EP19886281.5A patent/EP3884925A4/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007504091A (ja) * | 2003-05-21 | 2007-03-01 | ハンファ ケミカル コーポレイション | 金属酸化物固溶体、その製造および用途 |
JP2008279056A (ja) * | 2007-05-10 | 2008-11-20 | Toshiba Corp | 衣類洗濯機 |
JP2012521442A (ja) * | 2009-03-23 | 2012-09-13 | コボ プロダクツ インコーポレイテッド | 自己分散性金属酸化物コーティング粉末、その製造方法及び使用 |
US20110097288A1 (en) * | 2009-10-26 | 2011-04-28 | Frank Janssen | Sun Protection Composition |
US9669055B1 (en) * | 2014-04-11 | 2017-06-06 | Marshall University Research Corporation | Methods for treating sepsis |
CN106745166A (zh) * | 2016-11-24 | 2017-05-31 | 郑州轻工业学院 | 一种量子点氧化铈/改性氧化铈纳米材料的合成方法 |
CN107286540A (zh) * | 2017-08-03 | 2017-10-24 | 合肥安力电力工程有限公司 | 一种阻燃耐候高强电力穿线管材及其制备方法 |
CN107880324A (zh) * | 2017-11-14 | 2018-04-06 | 常德金德新材料科技股份有限公司 | 一种壳聚糖/多层杂化纳米粒子抗菌保鲜膜的制备方法 |
Non-Patent Citations (1)
Title |
---|
"Urea-based hydrothermally derived homogeneous nanostructured Ce1-xZrxO2 (x=0-0.8) solid solutions: A", J. PHYS. CHEM. B, vol. 108, JPN6022021399, 2004, pages 12481 - 12488, ISSN: 0005064473 * |
Also Published As
Publication number | Publication date |
---|---|
KR102678102B1 (ko) | 2024-06-26 |
EP3884925A4 (en) | 2022-01-26 |
WO2020106037A1 (ko) | 2020-05-28 |
CN113056255B (zh) | 2023-12-08 |
EP3884925A1 (en) | 2021-09-29 |
US20210401687A1 (en) | 2021-12-30 |
KR20200058197A (ko) | 2020-05-27 |
CN113056255A (zh) | 2021-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6402395B2 (ja) | 日焼け止め局所用組成物の二酸化チタンおよびシリカ | |
ES2843515T3 (es) | Composición que contiene partículas de material compuesto para filtrar la radiación UV, con un tamaño medio superior a 0,1 micras, y partículas de aerogel de sílice hidrofóbicas | |
KR101700977B1 (ko) | 유중수형 유화 선스크린 화장료 | |
CN108472515A (zh) | 光保护性化妆品组合物及获得该组合物的方法 | |
JP7350011B2 (ja) | 形状記憶日焼け止め組成物 | |
JP2022509077A (ja) | 表面欠陥が形成された酸化セリウム粒子を含む日焼け止め組成物、及びその製造方法 | |
US20120321682A1 (en) | Cosmetic compositions comprising mesoporous titania and methods of use | |
EP2474300A1 (en) | Composition for cosmetic preparation having ultraviolet shielding effect and sebum solidifying ability, and cosmetic preparation | |
KR20200016974A (ko) | Ir 보호를 위한 이산화 티타늄 입자를 사용하는 화장품 조성물 | |
JP2021519342A (ja) | 二酸化チタン | |
EA024856B1 (ru) | Фотостабильная солнцезащитная композиция | |
JP6113899B2 (ja) | 日焼け止め化粧料 | |
KR102678100B1 (ko) | 수분산 및 유분산된 세륨옥사이드 입자를 포함하는 자외선 차단제 조성물 및 이의 제조방법 | |
KR20210036785A (ko) | 표면개질된 세륨옥사이드 플레이크 및 이를 포함하는 자외선 차단제 조성물 | |
KR20210075074A (ko) | 이산화티탄 분산액 | |
KR20210015461A (ko) | 세륨옥사이드 플레이크 및 이를 포함하는 자외선 차단제 조성물 | |
KR102678098B1 (ko) | 표면개질된 세륨옥사이드 입자 및 유기자외선차단제를 포함하는 자외선 차단제 조성물 및 이의 제조방법 | |
JP2024071451A (ja) | 少なくとも5質量%の酸化チタン、α-シアノジフェニルアクリレート誘導体、及び4-ヒドロキシベンジリデンマロネート又は4-ヒドロキシシンナメート誘導体を含む組成物 | |
KR20210036786A (ko) | 세륨옥사이드 플레이크 및 표면개질된 세륨옥사이드 입자를 포함하는 자외선 차단제 조성물 | |
EP3884926A1 (en) | Ultraviolet ray-shielding agent composition absorbing radiation in uva range and preparation method therefor | |
KR20210015463A (ko) | 세륨옥사이드 플레이크를 포함하는 자외선 차단제 조성물 | |
KR20210036787A (ko) | 세륨옥사이드 플레이크 및 유기 자외선 차단제를 포함하는 자외선 차단제 조성물 | |
KR20210036784A (ko) | 실리콘 유도체로 표면개질된 세륨옥사이드 입자를 포함하는 자외선 차단제 조성물 및 이의 제조방법 | |
KR20210024769A (ko) | 엠보싱된 세륨옥사이드 플레이크 및 이를 포함하는 자외선 차단제 조성물 | |
JP2000212029A (ja) | 新規金属化合物分散体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210604 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20220426 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220531 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220830 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20221122 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230320 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20230320 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20230328 |
|
C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20230404 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20230526 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20240404 |